Silvia Vázquez Cuesta-rekin lankidetzan egindako argitalpenak (10)

2024

  1. Economic Burden of Clostridioides difficile Infection in European Countries

    Advances in experimental medicine and biology, Vol. 1435, pp. 1-12

  2. Impact of the Mediterranean Diet on the Gut Microbiome of a Well-Defined Cohort of Healthy Individuals

    Nutrients, Vol. 16, Núm. 6

2023

  1. Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  2. Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection

    Frontiers in Cellular and Infection Microbiology, Vol. 13

2022

  1. Clostridioides difficile infection epidemiology and clinical characteristics in COVID-19 pandemic

    Frontiers in Medicine, Vol. 9

2020

  1. Clostridioides difficile contamination in a clinical microbiology laboratory?

    Clinical Microbiology and Infection, Vol. 26, Núm. 3, pp. 340-344

  2. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: experience with lyophilized oral capsules

    Journal of Hospital Infection, Vol. 105, Núm. 2, pp. 319-324

  3. Role of Clostridioides difficile in hospital environment and healthcare workers

    Anaerobe, Vol. 63

2019

  1. Is it reasonable to perform fecal microbiota transplantation for recurrent clostridium difficile infection in patients with liver cirrhosis?

    Revista Espanola de Quimioterapia

2017

  1. Rifaximin-resistant Clostridium difficile strains isolated from symptomatic patients

    Anaerobe, Vol. 48, pp. 269-272